Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Lung Neoplasms"" wg kryterium: Temat


Tytuł :
Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines.
Autorzy :
Ericson Lindquist K; Department of Clinical Sciences Lund, Division of Pathology, Lund University, Lund, Sweden.; Department of Genetics and Pathology, Laboratory Medicine Region Skåne, Lund, Sweden.
Ciornei C; Department of Genetics and Pathology, Laboratory Medicine Region Skåne, Lund, Sweden.
Westbom-Fremer S; Department of Genetics and Pathology, Laboratory Medicine Region Skåne, Lund, Sweden.; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden.
Gudinaviciene I; Department of Genetics and Pathology, Laboratory Medicine Region Skåne, Lund, Sweden.
Ehinger A; Department of Genetics and Pathology, Laboratory Medicine Region Skåne, Lund, Sweden.; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden.
Mylona N; Department of Genetics and Pathology, Laboratory Medicine Region Skåne, Lund, Sweden.
Urdar R; Department of Genetics and Pathology, Laboratory Medicine Region Skåne, Lund, Sweden.
Lianou M; Department of Genetics and Pathology, Laboratory Medicine Region Skåne, Lund, Sweden.
Svensson F; Department of Pathology and Cytology, Halland Hospital Halmstad, Halmstad, Sweden.
Seidal T; Department of Pathology and Cytology, Halland Hospital Halmstad, Halmstad, Sweden.
Haglund F; Department of Clinical Pathology and Cytology, Karolinska University Hospital Solna, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
Dobra K; Department of Pathology, Division of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.; Department of Clinical Pathology and Cytology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Béndek M; Department of Clinical Pathology and Cytology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Bardóczi E; Department of Clinical Pathology and Cytology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Szablewska A; Department of Pathology and Cytology, Blekinge Hospital Karlskrona, Karlskrona, Sweden.
Witkowski M; Department of Pathology, Kalmar County Hospital, Kalmar, Sweden.
Ramnefjell M; Department of Pathology, Haukeland University Hospital, Bergen, Norway.
De Las Casas LE; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Gulyas M; Department of Immunology, Genetics and Pathology, Uppsala University and Uppsala University Hospital, Uppsala, Sweden.
Hegedus A; Department of Immunology, Genetics and Pathology, Uppsala University and Uppsala University Hospital, Uppsala, Sweden.
Micke P; Department of Immunology, Genetics and Pathology, Uppsala University and Uppsala University Hospital, Uppsala, Sweden.
Brunnström H; Department of Clinical Sciences Lund, Division of Pathology, Lund University, Lund, Sweden .; Department of Genetics and Pathology, Laboratory Medicine Region Skåne, Lund, Sweden.
Pokaż więcej
Źródło :
Journal of clinical pathology [J Clin Pathol] 2022 May; Vol. 75 (5), pp. 302-309. Date of Electronic Publication: 2021 Feb 05.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/pathology
Carcinoma, Squamous Cell*/pathology
Lung Neoplasms*/diagnosis
Lung Neoplasms*/pathology
Biomarkers, Tumor ; Biopsy ; Humans ; Immunohistochemistry
Czasopismo naukowe
Tytuł :
Feasibility of diffusion-weighted magnetic resonance imaging in evaluation of early therapeutic response after CT-guided microwave ablation of inoperable lung neoplasms.
Autorzy :
Vogl TJ; Institute for Diagnostic and Interventional Radiology, Johan Wolfgang Goethe - University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Emara EH; Institute for Diagnostic and Interventional Radiology, Johan Wolfgang Goethe - University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.; Department of Diagnostic and Interventional Radiology, Kafrelsheikh University, Kafr Elsheikh, Egypt.
Elhawash E; Institute for Diagnostic and Interventional Radiology, Johan Wolfgang Goethe - University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.; Department of Diagnostic and Interventional Radiology, University of Alexandria, Alexandria, Egypt.
Naguib NNN; Institute for Diagnostic and Interventional Radiology, Johan Wolfgang Goethe - University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.; Department of Diagnostic and Interventional Radiology, University of Alexandria, Alexandria, Egypt.
Aboelezz MO; Department of Radiology, University of Zagazig, Zagazig, Egypt.
Abdelrahman HM; Department of Radiology, University of Zagazig, Zagazig, Egypt.
Saber S; Department of Radiology, University of Zagazig, Zagazig, Egypt.
Nour-Eldin NA; Institute for Diagnostic and Interventional Radiology, Johan Wolfgang Goethe - University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. .; Department of Diagnostic and Interventional Radiology, Cairo University Hospital, Cairo, Egypt. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2022 May; Vol. 32 (5), pp. 3288-3296. Date of Electronic Publication: 2021 Nov 19.
Typ publikacji :
Journal Article
MeSH Terms :
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/surgery
Microwaves*/therapeutic use
Aged ; Diffusion Magnetic Resonance Imaging/methods ; Feasibility Studies ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Retrospective Studies ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer.
Autorzy :
Gragnano G; Public Health, University of Naples Federico II, Naples, Italy.
Nacchio M; Public Health, University of Naples Federico II, Naples, Italy.
Sgariglia R; Public Health, University of Naples Federico II, Naples, Italy.
Conticelli F; Public Health, University of Naples Federico II, Naples, Italy.
Iaccarino A; Public Health, University of Naples Federico II, Naples, Italy.
De Luca C; Public Health, University of Naples Federico II, Naples, Italy.
Troncone G; Public Health, University of Naples Federico II, Naples, Italy .
Malapelle U; Public Health, University of Naples Federico II, Naples, Italy.
Pokaż więcej
Źródło :
Journal of clinical pathology [J Clin Pathol] 2022 May; Vol. 75 (5), pp. 350-353. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Cell-Free Nucleic Acids*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
DNA Mutational Analysis/methods ; Humans ; Liquid Biopsy ; Mutation ; Proto-Oncogene Proteins p21(ras)/genetics ; Real-Time Polymerase Chain Reaction
Czasopismo naukowe
Tytuł :
Tumorous tissue characterization using integrated 18F-FDG PET/dual-energy CT in lung cancer: Combining iodine enhancement and glycolytic activity.
Autorzy :
Martin SS; Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany.
Muscogiuri E; Division of Cardiothoracic Imaging, Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA; Institute of Radiology, University of Rome 'Sapienza', Rome, Italy.
Burchett PF; Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA.
van Assen M; Division of Cardiothoracic Imaging, Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
Tessarin G; Division of Cardiothoracic Imaging, Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA; Department of Medicine-DIMED, Institute of Radiology, University of Padova, Italy.
Vogl TJ; Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany.
Schoepf UJ; Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA.
De Cecco CN; Division of Cardiothoracic Imaging, Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA. Electronic address: .
Pokaż więcej
Źródło :
European journal of radiology [Eur J Radiol] 2022 May; Vol. 150, pp. 110116. Date of Electronic Publication: 2021 Dec 23.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/pathology
Iodine*
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Fluorodeoxyglucose F18 ; Humans ; Neoplasm Staging ; Pilot Projects ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography/methods ; Radiopharmaceuticals ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Tytuł :
[Current Status and Progress of Thermal Ablation Combined with Immunotherapy for Lung Tumors].
Autorzy :
Liu B; Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Pokaż więcej
Źródło :
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 Apr 20; Vol. 25 (4), pp. 266-271.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hyperthermia, Induced*
Lung Neoplasms*/pathology
Lung Neoplasms*/surgery
Combined Modality Therapy ; Humans ; Immunotherapy ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
[Clinical Study of Artificial Intelligence-assisted Diagnosis System in Predicting the 
Invasive Subtypes of Early-stage Lung Adenocarcinoma Appearing as Pulmonary Nodules].
Autorzy :
Su Z; Department of Thoracic Surgery, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, 
Lanzhou 730030, China.
Mao W; Department of Thoracic Surgery, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, 
Lanzhou 730030, China.
Li B; Department of Thoracic Surgery, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, 
Lanzhou 730030, China.
Zheng Z; Department of Thoracic Surgery, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, 
Lanzhou 730030, China.
Yang B; Department of Thoracic Surgery, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, 
Lanzhou 730030, China.
Ren M; Department of Thoracic Surgery, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, 
Lanzhou 730030, China.
Song T; Department of Thoracic Surgery, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, 
Lanzhou 730030, China.
Feng H; Department of Thoracic Surgery, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, 
Lanzhou 730030, China.
Meng Y; Department of Thoracic Surgery, Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, 
Lanzhou 730030, China.
Pokaż więcej
Źródło :
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 Apr 20; Vol. 25 (4), pp. 245-252.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Multiple Pulmonary Nodules*
Artificial Intelligence ; Humans ; Neoplasm Invasiveness ; Retrospective Studies
Czasopismo naukowe
Tytuł :
[Clinical Characteristics and Risk Factors Analysis for Visceral Pleural Invasion in 
Mixed Ground-glass Nodular Lung Adenocarcinoma].
Autorzy :
Fu C; The First Clinical Medical College of Nanjing Medical University, Nanjing 210000, China.
Jiang Y; The First Clinical Medical College of Nanjing Medical University, Nanjing 210000, China.
Ge J; The First Clinical Medical College of Nanjing Medical University, Nanjing 210000, China.
Yuan M; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Wang J; Department of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Pokaż więcej
Źródło :
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 Apr 20; Vol. 25 (4), pp. 236-244.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/surgery
Female ; Humans ; Male ; Neoplasm Invasiveness ; Pleura/pathology ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
[Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
Autorzy :
Gu YC; Department of Medical Oncolo1. Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Liu Y; Department of Radiology, Peking University Third Hospital, Beijing 100191, China.
Xie C; Department of Endocrinology, Peking University Third Hospital, Beijing 100191, China.
Cao BS; Department of Medical Oncolo1. Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Pokaż więcej
Źródło :
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences [Beijing Da Xue Xue Bao Yi Xue Ban] 2022 Apr 18; Vol. 54 (2), pp. 369-375.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adenocarcinoma of Lung*/drug therapy
Hyponatremia*/chemically induced
Hyponatremia*/drug therapy
Hypopituitarism*/drug therapy
Lung Neoplasms*/drug therapy
Lung Neoplasms*/pathology
Pneumonia*
Adrenocorticotropic Hormone/therapeutic use ; Aged ; B7-H1 Antigen/therapeutic use ; Humans ; Hydrocortisone/therapeutic use ; Immune Checkpoint Inhibitors ; Male ; Methylprednisolone/therapeutic use ; Middle Aged ; Nausea/drug therapy ; Pituitary Gland/pathology ; Prednisone/therapeutic use ; Programmed Cell Death 1 Receptor/therapeutic use ; Prolactin/therapeutic use
Czasopismo naukowe
Tytuł :
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC.
Autorzy :
Frigola J; Thoracic Cancers Translational Genomics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Carbonell C; Thoracic Cancers Translational Genomics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Irazno P; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Pardo N; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Callejo A; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Cedres S; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Martinez-Marti A; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Navarro A; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Soleda M; Thoracic Cancers Translational Genomics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Jimenez J; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Hernandez-Losa J; Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain.
Vivancos A; Cancer Genomics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Felip E; Thoracic Cancers Translational Genomics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain .; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Amat R; Thoracic Cancers Translational Genomics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain .; Clinical Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Pokaż więcej
Źródło :
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Apr; Vol. 10 (4).
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung*
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Chromosome Aberrations ; Humans ; Male ; Survival Analysis
Czasopismo naukowe
Tytuł :
Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer.
Autorzy :
Rivera-Concepcion J; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Uprety D; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.
Adjei AA; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło :
Cancer research and treatment [Cancer Res Treat] 2022 Apr; Vol. 54 (2), pp. 315-329. Date of Electronic Publication: 2022 Feb 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Precision Medicine
Czasopismo naukowe
Tytuł :
Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes.
Autorzy :
Zhang J; Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, Victorian Comprehensive Cancer Centre, Melbourne, Australia. Electronic address: .
IJzerman MJ; Cancer Health Services Research Unit, Centre for Health Policy, School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victorian Comprehensive Cancer Centre, Melbourne, Australia.
Oberoi J; Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, Victorian Comprehensive Cancer Centre, Melbourne, Australia.
Karnchanachari N; Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, Victorian Comprehensive Cancer Centre, Melbourne, Australia; Primary Care Collaborative Cancer Clinical Trials Group (PC4), Melbourne, Australia.
Bergin RJ; Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, Victorian Comprehensive Cancer Centre, Melbourne, Australia; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Franchini F; Cancer Health Services Research Unit, Centre for Health Policy, School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victorian Comprehensive Cancer Centre, Melbourne, Australia.
Druce P; Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, Victorian Comprehensive Cancer Centre, Melbourne, Australia; Primary Care Collaborative Cancer Clinical Trials Group (PC4), Melbourne, Australia; The Central Clinical School, Monash University, Melbourne, Australia; The School of Public Health and Preventative Medicine, Monash University, Melbourne, Australia.
Wang X; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, USA.
Emery JD; Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, Victorian Comprehensive Cancer Centre, Melbourne, Australia; Primary Care Collaborative Cancer Clinical Trials Group (PC4), Melbourne, Australia.
Pokaż więcej
Źródło :
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2022 Apr; Vol. 166, pp. 27-39. Date of Electronic Publication: 2022 Jan 25.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms :
Lung Neoplasms*/diagnosis
Lung Neoplasms*/therapy
Humans ; Risk Factors
Czasopismo naukowe
Tytuł :
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma.
Autorzy :
Huang YH; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Hsu KH; Division of Critical Care and Respiratory Therapy, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Chin CS; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Tseng JS; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Yang TY; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Chen KC; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Su KY; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Yu SL; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Center of Genomic and Precision Medicine, National Taiwan University, Taipei,Taiwan.; Institute of Medical Device and Imaging, College of Medicine, National Taiwan University, Taipei, Taiwan.; Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chen JJW; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Chang GC; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Pokaż więcej
Źródło :
Cancer research and treatment [Cancer Res Treat] 2022 Apr; Vol. 54 (2), pp. 434-444. Date of Electronic Publication: 2021 Aug 02.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Afatinib/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab/adverse effects ; ErbB Receptors/genetics ; Erlotinib Hydrochloride/adverse effects ; Gefitinib/therapeutic use ; Humans ; Mutation ; Protein Kinase Inhibitors/adverse effects
Czasopismo naukowe
Tytuł :
Basal segment deep wedge resection for lung cancer with pulmonary fibrosis.
Autorzy :
Tane S; Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, 2-10-39, Shibata, Kita-ward, Osaka, 530-0012, Japan. .
Ando Y; Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, 2-10-39, Shibata, Kita-ward, Osaka, 530-0012, Japan.
Matsumoto G; Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, 2-10-39, Shibata, Kita-ward, Osaka, 530-0012, Japan.
Ueda S; Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, 2-10-39, Shibata, Kita-ward, Osaka, 530-0012, Japan.
Uchino K; Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, 2-10-39, Shibata, Kita-ward, Osaka, 530-0012, Japan.
Pokaż więcej
Źródło :
General thoracic and cardiovascular surgery [Gen Thorac Cardiovasc Surg] 2022 Apr; Vol. 70 (4), pp. 413-415. Date of Electronic Publication: 2022 Jan 27.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/complications
Carcinoma, Non-Small-Cell Lung*/pathology
Carcinoma, Non-Small-Cell Lung*/surgery
Idiopathic Pulmonary Fibrosis*/complications
Idiopathic Pulmonary Fibrosis*/surgery
Lung Neoplasms*/complications
Lung Neoplasms*/pathology
Lung Neoplasms*/surgery
Humans ; Lung/pathology
Czasopismo naukowe
Tytuł :
Preoperative percutaneous needle lung biopsy techniques and ipsilateral pleural recurrence in stage I lung cancer.
Autorzy :
Kim MG; Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Yang BR; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.
Park CM; Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.; Medical Research Collaborating Center, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Republic of Korea.; Institute of Medical and Biological Engineering, Medical Research Center, Seoul National University, Seoul, Republic of Korea.
Yoon SH; Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2022 Apr; Vol. 32 (4), pp. 2683-2692. Date of Electronic Publication: 2022 Jan 10.
Typ publikacji :
Journal Article
MeSH Terms :
Lung Neoplasms*/complications
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/surgery
Pleural Neoplasms*/pathology
Biopsy, Needle/methods ; Humans ; Lung/diagnostic imaging ; Lung/pathology ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Molecular profiling of advanced non-small cell lung cancer in the era of immunotherapy approach: a multicenter Italian observational prospective study of biomarker screening in daily clinical practice.
Autorzy :
Vavala T; SC Oncology, ASL CN1, Saluzzo, Italy .; Department of Oncology, University of Turin, Torino, Italy.
Malapelle U; Department of Public Health, University of Naples Federico II, Napoli, Campania, Italy.
Veggiani C; Pathology Unit, Hospital Maggiore della Carità, Novara, Piemonte, Italy.
Ludovini V; Molecular Biology Laboratory, Medical Oncology Division, Ospedale Santa Maria della Misericordia, Perugia, Umbria, Italy.
Papotti M; Department of Oncology, Unversity of Torino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
Leone A; Department of Pathology, San Camillo Forlanini Hospital, Rome, Italy.
Graziano P; Unit of Pathology, IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Puglia, Italy.
Minari R; UO Medical Oncology, University Hospital of Parma, Parma, Italy.
Bono F; UO Anatomo-Pathology, San Gerardo Hospital, Monza, Italy.
Sapino A; Department of Surgical Pathology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Piemonte, Italy.; Department of Medical Sciences, University of Turin, Torino, Piemonte, Italy.
Manotti L; Department of Oncology, UO Anatomo-Pathology, Hospital of Cremona, Cremona, Lombardia, Italy.
Troncone G; Department of Public Health, University of Naples Federico II, Napoli, Campania, Italy.
Pisapia P; Department of Public Health, University of Naples Federico II, Napoli, Campania, Italy.
Girlando S; Anatomo-pathology Unit, Santa Chiara Hospital, Trento, Italy.
Buffoni L; Department of Oncology, University of Turin, Torino, Italy.
Righi L; Department of Oncology, University of Turin, Torino, Italy.
Colantonio I; Department of Oncologia, Azienda Ospedaliera S Croce e Carle Cuneo, Cuneo, Piemonte, Italy.
Bertetto O; Rete Oncologica Piemonte e Valle d'Aosta Department, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Piemonte, Italy.
Novello S; Department of Oncology, University of Turin, Torino, Italy.
Pokaż więcej
Źródło :
Journal of clinical pathology [J Clin Pathol] 2022 Apr; Vol. 75 (4), pp. 234-240. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Biomarkers ; Early Detection of Cancer ; Humans ; Immunotherapy ; Mutation ; Prospective Studies ; Protein-Tyrosine Kinases/genetics ; Proto-Oncogene Proteins/genetics
Czasopismo naukowe
Tytuł :
[Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer].
Autorzy :
Wang R; The Second Department of Respiratory, Shanxi Provincial Cancer Hospital, Taiyuan 030000, China.
Pan S; The Second Clinical Medical College of Shanxi Medical University, Taiyuan 030000, China.
Song X; The Second Department of Respiratory, Shanxi Provincial Cancer Hospital, Taiyuan 030000, China.
Pokaż więcej
Źródło :
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 Mar 20; Vol. 25 (3), pp. 174-182.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
ErbB Receptors/genetics ; Humans ; Mutation ; Protein Kinase Inhibitors/therapeutic use ; Tumor Suppressor Protein p53/genetics
Czasopismo naukowe
Tytuł :
[Relationship between EGFR, ALK Gene Mutation and Imaging 
and Pathological Features in Invasive Lung Adenocarcinoma].
Autorzy :
Yang H; Department of Thoracic Surgery, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University, 
Nanjing 210029, China.
Liu Z; Department of Thoracic Surgery, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University, 
Nanjing 210029, China.
Wang H; Department of Thoracic Surgery, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University, 
Nanjing 210029, China.
Chen L; Department of Thoracic Surgery, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University, 
Nanjing 210029, China.
Wang J; Department of Thoracic Surgery, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University, 
Nanjing 210029, China.
Wen W; Department of Thoracic Surgery, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University, 
Nanjing 210029, China.
Xu X; Department of Thoracic Surgery, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University, 
Nanjing 210029, China.
Zhu Q; Department of Thoracic Surgery, Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Nanjing Medical University, 
Nanjing 210029, China.
Pokaż więcej
Źródło :
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 Mar 20; Vol. 25 (3), pp. 147-155.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/genetics
Anaplastic Lymphoma Kinase*/genetics
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Aged ; ErbB Receptors/genetics ; Female ; Genes, erbB-1 ; Humans ; Mutation ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Tytuł :
[Targeted Therapy and Mechanism of Drug Resistance in Non-small Cell Lung Cancer 
with Epidermal Growth Factor Receptor Gene Mutation].
Autorzy :
Huang J; The Second School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.
Wang H; Department of Lung Oncology, 
Affiliated Hospital of the PLA Military Academy of Medical Sciences, Beijing 100071, China.
Pokaż więcej
Źródło :
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 Mar 20; Vol. 25 (3), pp. 183-192.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Acrylamides ; Drug Resistance, Neoplasm/genetics ; ErbB Receptors/genetics ; Genes, erbB-1 ; Humans ; Indoles ; Mutation ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Pyrimidines
Czasopismo naukowe
Tytuł :
[Research Progress of Immunotherapy for Non-small Cell Lung Cancer 
with Drive Gene Mutation].
Autorzy :
Deng R; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.; Department of 
Oncology, Zhuzhou Second Hospital, Zhuzhou 412000, China.
Zeng Y; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Pan Y; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Hu C; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.; Hunan Cancer Mega-data Intelligent Application and Engineering 
Research Centre, Changsha 410011, China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.; Hunan Cancer Mega-data Intelligent Application and Engineering 
Research Centre, Changsha 410011, China.; Hunan Key Laboratory of Tumor Models and Individualized Medicine, Changsha 410011, China.; Hunan Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer, Changsha 410011, China.
Pokaż więcej
Źródło :
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 Mar 20; Vol. 25 (3), pp. 201-206.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/therapy
Lung Neoplasms*/drug therapy
Lung Neoplasms*/therapy
Humans ; Immunotherapy ; Molecular Targeted Therapy ; Mutation
Czasopismo naukowe
Tytuł :
[Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients 
Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis: 
A Single-center Retrospective Study].
Autorzy :
Yin W; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Zhang H; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China.
Gu Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Yi F; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Li Q; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Liu Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Yao Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Liu Z; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Cao B; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Pokaż więcej
Źródło :
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 Mar 20; Vol. 25 (3), pp. 156-166.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung*/complications
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Pleural Effusion*/complications
ErbB Receptors/genetics ; Humans ; Mutation ; Prognosis ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies